Science Explorer Back to mapMap
Discussion
Topic · Epidemiology

Hepatitis B Virus Studies

Hepatitis B Virus Studies is a research topic within Epidemiology. Science Explorer counts 58k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the epidemiology, clinical management, antiviral therapy, and global burden of hepatitis B virus (HBV) infection. It covers topics such as chronic hepatitis B, hepatocellular carcinoma, viral hepatitis, antiviral therapy, vaccine prevention, and the immune response to HBV infection.

  • Hepatitis B Virus
  • Chronic Hepatitis B
  • Viral Hepatitis
  • HBV Infection
  • Hepatocellular Carcinoma
  • Antiviral Therapy
  • Global Burden
  • Vaccine Prevention
  • Liver Disease
  • Immune Response
Research works
58k
fractional, since 1950
In the world top 10%
5.8k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
-9%
the tick is no change
Largest producer
China
34% of the 10 largest, 2022-now
Hepatitis B Virus Studies

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Hepatitis B Virus Studies research?

By volume, China and the United States publish the most (1.6k and 1.2k works in 2022-now).

By volume, 2022-now

  1. 1 China 1.6k works
  2. 2 United States 1.2k works
  3. 3 India 476 works
  4. 4 Japan 250 works
  5. 5 United Kingdom 231 works
  6. 6 Türkiye 230 works
  7. 7 France 216 works
  8. 8 Germany 215 works
  9. 9 Brazil 209 works
  10. 10 Pakistan 200 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

China: 33.5%United States: 25.0%India: 9.7%Japan: 5.1%6 others listed: 26.6%34%largest
China1,638 · 33.5%United States1,224 · 25.0%India476 · 9.7%Japan250 · 5.1%6 others listed1,301 · 26.6%

Shares of the rows listed above, not of the whole node.

Which institutions lead Hepatitis B Virus Studies research?

By volume in 2022-now, Sun Yat-sen University publishes the most Hepatitis B Virus Studies research, followed by Capital Medical University and Peking University.

By volume, 2022-now

  1. 1 Sun Yat-sen UniversityChina 59 works
  2. 2 Capital Medical UniversityChina 56 works
  3. 3 Peking UniversityChina 50 works
  4. 4 Fudan UniversityChina 46 works
  5. 5 Zhejiang UniversityChina 41 works
  6. 6 Chongqing Medical UniversityChina 40 works
  7. 7 Sichuan UniversityChina 38 works
  8. 8 Fujian Medical UniversityChina 37 works
  9. 9 InsermFrance 36 works
  10. 10 University of North Carolina at Chapel HillUnited States 36 works

Who are the leading researchers in Hepatitis B Virus Studies?

The most-cited researchers publishing on Hepatitis B Virus Studies include Ahmedin Jemal, Christopher J L Murray and Freddie Bray.

  1. 1 Ahmedin Jemal United States 761k citations
  2. 2 Christopher J L Murray United States 583k citations
  3. 3 Freddie Bray France 550k citations
  4. 4 Simon Iain Hay United States 452k citations
  5. 5 Theo Vos United States 439k citations
  6. 6 Ali H. Mokdad United States 429k citations
  7. 7 Guido Kroemer France 386k citations
  8. 8 Zulfiqar Ahmed Bhutta Pakistan 371k citations
  9. 9 Elaine R. Mardis United States 346k citations
  10. 10 Shizuo Akira Japan 342k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Hepatitis B Virus Studies?

The most cited paper in Hepatitis B Virus Studies is "Human papillomavirus is a necessary cause of invasive cervical cancer worldwide" (Jan M.M. Walboomers, Marcel V. Jacobs, M. Michele Manos et al., 1999), with 9,115 citations. Next come "Management of Hepatocellular Carcinoma: An Update Δσ" (8,176) and "Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome" (6,911).

Most cited papers
#PaperReleasedCitations
1 Human papillomavirus is a necessary cause of invasive cervical cancer worldwide Jan M.M. Walboomers, Marcel V. Jacobs, M. Michele Manos et al. · The Journal of Pathology Open access Sep 1999 9,115
2 Management of Hepatocellular Carcinoma: An Update Δσ Jordi Bruix, Morris Sherman · Hepatology Open access 19 Jan 2011 8,176
3 Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis Genome Qui‐Lim Choo, George C. Kuo, Amy J. Weiner et al. · Science 21 Apr 1989 6,911
4 Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial Michael Peter Manns, John G. McHutchison, Stuart C. Gordon et al. · The Lancet Sep 2001 6,056
5 Management of Hepatocellular Carcinoma * Jordi Bruix, Morris Sherman · Hepatology Open access 26 Oct 2005 5,904
All 99 most cited papers, with filters and sorting

Where is Hepatitis B Virus Studies research done?

The largest centres of Hepatitis B Virus Studies research in 2022-now are Beijing (China), Guangzhou (China), Shanghai (China) and London (United Kingdom). Among places with at least 20 works in it, it is an unusually large share of all research in Yaoundé.

Largest cities, 2022-now

  1. 1 BeijingChina 261 works
  2. 2 GuangzhouChina 135 works
  3. 3 ShanghaiChina 118 works
  4. 4 LondonUnited Kingdom 103 works
  5. 5 SeoulSouth Korea 96 works
  6. 6 ParisFrance 96 works
  7. 7 TaipeiTaiwan 74 works
  8. 8 New DelhiIndia 69 works
  9. 9 HangzhouChina 67 works
  10. 10 NanjingChina 64 works

Where it is the local speciality

  1. YaoundéCM · 20.7 works10×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Hepatitis B Virus Studies than the world average.

See Hepatitis B Virus Studies on the map

Where is the best place to study Hepatitis B Virus Studies?

Among universities, judged by research, University of Hong Kong, Chinese University of Hong Kong and National Taiwan University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 17.29%fractional works in this field (log) →share of work in the world top 10% →Chinese University o…University of Hong K…National Taiwan Univ…Peking University
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1University of Hong KongChina 74.123.2%3.3×21 +3.6%
2Chinese University of Hong KongChina 68.824.3%4.2×21 -21.0%
3National Taiwan UniversityTaiwan 67.321.2%6.2×28 -11.4%
4Peking UniversityChina 62.517.7%3.6×50 -13.6%
5Fujian Medical UniversityChina 61.312.6%9.9×37 +26.5%
6Harvard UniversityUnited States 61.119.4%1.4×31 -23.7%
7Capital Medical UniversityChina 60.612.6%7.6×56 -3.8%
8Medizinische Hochschule HannoverGermany 59.416.0%10.9×19 +54.8%
9Fudan UniversityChina 59.213.4%4.2×46 -8.1%
10London School of Hygiene & Tropical MedicineUnited Kingdom 59.112.5%9.4×10 +61.5%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Hepatitis B Virus Studies, country by country

Is Hepatitis B Virus Studies research growing?

Output in 2022-2025 was 9% lower than in 2018-2021, peaking in 2015.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Hepatitis B Virus Studies as a percentage of every work published that year, 0.034% in 2024.

still counting0.050%0.10%Hepatitis B Virus Studies0.030% in 202519801990200020102020

Fractional works of Hepatitis B Virus Studies over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Hepatitis B Virus Studies10.4% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Questions people ask

Who is researching a cure for hepatitis B?

By volume in 2022-now, Sun Yat-sen University publishes the most Hepatitis B Virus Studies research, followed by Capital Medical University and Peking University. By volume, China and the United States publish the most (1.6k and 1.2k works in 2022-now).

All 1,273 questions in the Question Catalogue

Discussion

Ask a question or share a note about Hepatitis B Virus Studies. Posts are plain text and can be reported.